We demonstrated earlier that a novel class of synthetic small molecules, known as the PCAIs, diminish the levels of the Rho proteins (Rac1, Cdc42 and RhoA) and suppress F-actin remodeling in NSCLC cells thereby blocking cell migration and invasion [18]. The gene discussed is RAC1; the disease is non-small cell lung carcinoma.